Digital diagnostics deals with a common tool in which a person can easily collaborate across the entire application lifecycle by allowing quick isolation and resolution of issues. This new technology supports to progress in medical care system by contributing in the precision and correctness of the diagnostics output. Digital diagnostics categorizes, prioritizes and reports on hitches. Digital diagnostics tracks regular scans through every inch of your portfolio, from websites and widgets to social and mobile.
The process of digital diagnostics is now a common term for many medical device applications, the installed software delivers deep drill down into transactions from the end user through the back end. Digital diagnostics makes use of unified tools to hold the entire classification of medical device providers, consumers and healthcare professionals and hence grades in enhanced care quality and access, improved patient engagement, closing communication gaps, improved decision making by consumers and medical device providers & reduction in healthcare cost. Healthcare experts recommend that through digital diagnostics, programmed health assessments can be carried out virtually and electronically. The terrestrial barriers can be concentrated with this technology by making it conceivable to diagnose patients placed away from the diagnostic center and clinics.
The global digital diagnostics market is segmented on the basis of product type, end users and region. The product type include Oxitone, Cerora Borealis, Oto, Midmark IQvitals, IQecg, IQholter, IQspiro and IQstress, Lifepatch, Intelligent Breast Exam (iBE), Biomeme device, iBrain, Fever Smart, HealthPatch MD, VitalPatch, BioStampRC, Qardioarm, Qardiobase, and Qardiocore, HxM BT, HxM Smart, and BioHarness 3 and others.
Currently, manufacturing companies have established their individual mobile applications and software programs to make remote diagnostics conceivable. During the forecast period, it is projected that more cutting-edge high-end programs will be produced by the companies to diagnose patients irrespective of their physical existence in the diagnostic facility. The integration of medical codes linked with healthcare informatics software solutions requires additional IT investments. This IT trend will attract numerous start-up vendors and medical outsourcing solutions providers in the digital diagnostic market during the forecast period. The U.S. is a major market for digital diagnostics services because of advanced and improved healthcare IT infrastructure, launching reliable healthcare data prototypes. Advancement in information & technology and medical health applications, help minimize errors and heighten working procedures.
The key mass drivers supporting the market growth of digital diagnostics are growing awareness related to daily health diagnostics, patients are expected to prefer digital diagnostic over laboratory or hospital visit, and this technology platform is estimated to surge the approachability for patients as well as medical practitioners. Digital diagnostics market often depresses entry barriers, causing established boundaries between sectors to tumble. Moreover the nature of digital technology causes value chains to disaggregate, generating opportunities for focused, fast-moving entrants. New market competitors often scale up rapidly at lower cost and returns may grow swiftly as more customers will connect to the online network.
Expertise technology companies like Google, Microsoft & Apple are capitalizing significantly in this canvas. The initial utilizers of digital tools are individuals or parents, people with health issues and young adults. Even though still in its emerging stage, digital diagnostics market seems to offer a mix of suitability, customization, accessibility or simply the need to have a digital device. For e.g. Accenture is now offering better software tools to access the information from both the ends, such as from end user to the physician directly within seconds. For healthier patient experience. Information fed electronically or manually to mobile applications, such as “Well Docs BlueStar”, is analysed to guide the individual and send the synchronized data to their physician to track the progress. This optimises time and treatment proficiencies.
Based on geography, the global digital diagnostics market is segmented into five key regions, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is the leading regional market for digital diagnostics and is trailed by Europe due to the existence of a large number of population suffering with diseases, and high patient awareness related to disease diagnosis in these regions. Some countries from Asia–Pacific and Latin America are expected to enter the market late because of lack of digital infrastructure, and accessibility to advanced technology. However, rising healthcare expenditure, developing healthcare infrastructure and increasing awareness related to the disease diagnosis. However, poor healthcare facilities in underdeveloped and emerging countries which lack appropriate healthcare infrastructure and trained staff is anticipated to affect the adoption in these countries.
Some of the major players in the global digital diagnostics market include Neurovigil, Inc., Oxitone Medical Ltd., Cerora, CellScope, MidMark Corp., MC10, Inc., Qardio, Inc., Vital Connect, Fever Smart, UE LifeSciences, Inc., Biomeme, Medtronic, Inc. and others.
Request a brochure of this report to know what opportunities will emerge in the rapidly evolving Digital Diagnostics Market during 2016- 2024
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453